MedPath

Evaluation of the effect of herbal anti-asthma product along with standard treatment on the intervals and severity of moderate chronic asthma attacks in children and adolescents 6 to 18 years

Phase 2
Recruiting
Conditions
moderate persistent asthma.
Moderate persistent asthma
J45.4
Registration Number
IRCT20090808002306N6
Lead Sponsor
Esfahan University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria

All patients between 6 and 18 years old with chronic asthma in children and adolescents with moderate severity according to the Nelson Pediatrics textbook published in 2018 (page 202)
Do not use other drugs at the same time and outside the official treatment protocol that is effective on the disease.
No possible history of underlying cardiovascular, renal, hepatic and biliary tract diseases

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath